Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/31867| Title: | COVID-19 living evidence profile #1 (version 1.3): What is known about anticipated COVID-19 vaccine roll-out elements? |
| Authors: | Wilson, MG Bain, T Wang, Q Al-Khateeb, S Bhuiya, AR Alam, S DeMaio, P Gauvin, François-Pierre Ahmad, A Drakos, A Sharma, K Whitelaw, S Lavis, JN |
| Keywords: | COVID-19;vaccine;roll-out |
| Publication Date: | Feb-2021 |
| Citation: | Wilson MG, Bain T, Wang Q, Al-Khateeb S, Bhuiya A, Alam S, DeMaio P, Gauvin FP, Ahmad A, Drakos A, Sharma K, Whitelaw S, Lavis JN. COVID-19 living evidence profile #1 (version 1.3): What is known about anticipated COVID-19 vaccine roll-out elements? Hamilton: McMaster Health Forum, 11 February 2021. |
| Series/Report no.: | LEP 1.3; |
| Abstract: | An overview of the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies) and, if applicable, a scan of experiences from other countries and from Canadian provinces and territories, about anticipated COVID-19 vaccine roll-out elements in response to a decision-maker’s request. |
| URI: | http://hdl.handle.net/11375/31867 |
| Appears in Collections: | Living evidence profile |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| COVID-19 living evidence profile 1.3_What is known about anticipated COVID-19 vaccine roll-out elements.pdf | 654.27 kB | Adobe PDF | View/Open | |
| COVID-19 living evidence profile 1.3-appendix_What is known about anticipated COVID-19 vaccine roll-out elements.pdf | 1.55 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
